Preferential activation of type I interferon-mediated antitumor inflammatory signaling by CuS/MnO 2 /diAMP nanoparticles enhances anti-PD-1 therapy for sporadic colorectal cancer.

Autor: Peng J; Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China. rater.peng@163.com., Yang Q; Center of Scientific Research, Chengdu Medical College, Chengdu, 610500, Sichuan, China. yoyoyoung@cmc.edu.cn., Lei R; Center of Scientific Research, Chengdu Medical College, Chengdu, 610500, Sichuan, China., Wang Y; Center of Scientific Research, Chengdu Medical College, Chengdu, 610500, Sichuan, China., Liu G; Center of Scientific Research, Chengdu Medical College, Chengdu, 610500, Sichuan, China., Qian Z; Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China. anderson-qian@163.com.

Publikováno v: Journal of nanobiotechnology [J Nanobiotechnology] 2024 Nov 12; Vol. 22 (1), pp. 699. Date of Electronic Publication: 2024 Nov 12.